Back
Duke Energy Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Buy
62
DUK
Duke Energy
Last Price:
100.23
Seasonality Move:
1.03%
Buy
55
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
45.13
Seasonality Move:
-11.02%
Buy
62
Duke Energy (DUK)
is a Buy
Is Duke Energy a Buy, Sell or Hold?
- The current Duke Energy [DUK] share price is $100.23. The Score for DUK is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- DUK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $45.25. The Score for CRBP is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DUK Stock Price Chart
What is Duke Energy's stock price today?
-
The Duke Energy share price today is $100.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DUK is experiencing slight buying pressure.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $45.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
DUK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 45.25 | Sell |
| Chaikin Money Flow: | 175549 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.32 - 102.9) | Sell |
| Bollinger Bands (100): | (93.57 - 101.67) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 51.62 | Buy |
| Chaikin Money Flow: | 1520753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.2 - 48.24) | Buy |
| Bollinger Bands (100): | (31.14 - 46.02) | Buy |
DUK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.31 | Sell |
| 20-day SMA: | 101.67 | Sell |
| 50-day SMA: | 101.2 | Sell |
| 200-day SMA: | 95.12 | Buy |
| 8-day EMA: | 100.54 | Sell |
| 20-day EMA: | 101.1 | Sell |
| 50-day EMA: | 100.5 | Sell |
| 200-day EMA: | 96.91 | Buy |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.66 | Buy |
| 20-day SMA: | 45.82 | Sell |
| 50-day SMA: | 42.78 | Buy |
| 200-day SMA: | 22.9 | Buy |
| 8-day EMA: | 44.51 | Buy |
| 20-day EMA: | 44.85 | Buy |
| 50-day EMA: | 42.76 | Buy |
| 200-day EMA: | 28.27 | Buy |
Duke Energy Earnings Growth & DUK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.86 per share, an increase this year of $0.38 per share, and an increase next year of $0.36 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.70 per share, an increase next quarter of $0.13 per share, an increase this year of $5.96 per share, and an increase next year of $0.18 per share.
Duke Energy Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||